Detalles de la búsqueda
1.
Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry.
Dermatol Ther
; 34(2): e14808, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33491259
2.
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab.
J Am Acad Dermatol
; 82(4): 927-935, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31712178
3.
Dermatologists: Collaborating With Payers to Optimize Coverage Policies.
J Drugs Dermatol
; 16(3): 228-232, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28301618
4.
Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry.
Curr Med Res Opin
; 40(2): 315-323, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050693
5.
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies.
Dermatol Ther (Heidelb)
; 14(4): 933-952, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521874
6.
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab.
Adv Ther
; 41(4): 1672-1684, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443645
7.
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity.
Dermatol Ther (Heidelb)
; 14(6): 1615-1631, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38814433
8.
Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program.
Dermatol Ther (Heidelb)
; 13(8): 1831-1846, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434099
9.
The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study.
J Dermatolog Treat
; 33(3): 1707-1717, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33752555
10.
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy.
J Dermatolog Treat
; 33(5): 2510-2517, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34612129
11.
Psoriasis treatment patterns and outcomes with ixekizumab in a real-world setting: results from a single US dermatology referral practice.
J Dermatolog Treat
; 33(4): 2278-2284, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34236934
12.
US health care utilization and costs in adult patients with atopic dermatitis by disease severity.
J Manag Care Spec Pharm
; 28(1): 69-77, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34949118
13.
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases.
Adv Ther
; 39(7): 3214-3224, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570242
14.
Employment, Work Productivity, and Biologic Treatments in Self-Reported Axial Spondyloarthritis: a Cross-Sectional Study in a Female Predominant Population from the ArthritisPower Registry.
Rheumatol Ther
; 9(2): 663-677, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35191010
15.
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry.
Dermatol Ther (Heidelb)
; 12(12): 2797-2815, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331713
16.
Disease response and patient-reported outcomes among initiators of ixekizumab.
J Dermatolog Treat
; 33(3): 1538-1546, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33267635
17.
Treatment Satisfaction and Decision-making from the Patient Perspective in Axial Spondyloarthritis: Real-World Data from a Descriptive Cross-sectional Survey Study from the ArthritisPower Registry.
ACR Open Rheumatol
; 4(1): 85-94, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758105
18.
Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs.
J Manag Care Spec Pharm
; 28(2): 206-217, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35098751
19.
Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry.
J Comp Eff Res
; 10(2): 157-167, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355477
20.
Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis.
Adv Ther
; 38(7): 3948-3961, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34091866